Here are five points:
1. Dr. Cooper performed the procedure at Salt Lake Regional Medical Center in Salt Lake City, Utah.
2. The Safety Using NUsurface, or SUN, clinical trial aims to assess the safety and effectiveness of Active Implants’ NUsurface Meniscus Implant in restoring function to deteriorating meniscus cartilage.
3. The NUsurface Meniscus Implant has been used in Europe under CE Mark since 2008 and in Israel since 2011.
4. Dr. Andrew Cooper is orthopedic surgeon at Salt Lake Regional Medical Center.
5. He has completed a fellowship in sports medicine at the Steadman Hawkins Clinic in Denver.
More articles on devices:
Johnson & Johnson inks deal with HP for 3D printing technology: 5 key notes
5 key notes on clinical results from Medacta’s minimally invasive hip stem implant
Predictive Biotech beta launches spine deformity molecular diagnostic test: 4 key points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
